146 related articles for article (PubMed ID: 32999137)
1. Effects of M-1, a Major Metabolite of Sarpogrelate, on 5-HT-Induced Constriction of Isolated Human Internal Thoracic Artery.
Tanaka-Totoribe N; Hidaka M; Gamoh S; Yokota A; Nakamura E; Kuwabara M; Tsunezumi J; Yamamoto R
Biol Pharm Bull; 2020 Dec; 43(12):1979-1982. PubMed ID: 32999137
[TBL] [Abstract][Full Text] [Related]
2. Both 5-hydroxytryptamine 5-HT2A and 5-HT1B receptors are involved in the vasoconstrictor response to 5-HT in the human isolated internal thoracic artery.
Tanaka N; Nakamura E; Ohkura M; Kuwabara M; Yamashita A; Onitsuka T; Asada Y; Hisa H; Yamamoto R
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):836-40. PubMed ID: 18430065
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
Kodama A; Komori K; Kajikuri J; Itoh T
J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096
[TBL] [Abstract][Full Text] [Related]
4. Diabetes Mellitus Induces Hyperreactivity of 5-Hydroxytryptamine (5-HT)-Induced Constriction in Human Internal Thoracic Artery and Is Associated with Increase in the Membrane Protein Level of 5-HT
Shiba T; Yokota A; Gamoh S; Tanaka-Totoribe N; Kuwabara M; Nakamura E; Hayase T; Nakamura K; Yamamoto R
Biol Pharm Bull; 2018 May; 41(5):820-823. PubMed ID: 29434166
[TBL] [Abstract][Full Text] [Related]
5. Sarpogrelate dilates cerebral arteries in the absence of exogenous serotonin.
Kawamura M; Ishiguro M; Nagamine T; Houkin K
Neurol Med Chir (Tokyo); 2013; 53(5):291-8. PubMed ID: 23708219
[TBL] [Abstract][Full Text] [Related]
6. Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model.
Miyata K; Shimokawa H; Higo T; Yamawaki T; Katsumata N; Kandabashi T; Tanaka E; Takamura Y; Yogo K; Egashira K; Takeshita A
J Cardiovasc Pharmacol; 2000 Feb; 35(2):294-301. PubMed ID: 10672864
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
8. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
[TBL] [Abstract][Full Text] [Related]
9. Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts.
Fujita M; Minamino T; Sanada S; Asanuma H; Hirata A; Ogita H; Okada K; Tsukamoto O; Takashima S; Tomoike H; Node K; Hori M; Kitakaze M
J Mol Cell Cardiol; 2004 Dec; 37(6):1219-23. PubMed ID: 15572052
[TBL] [Abstract][Full Text] [Related]
10. Relative contributions of 5-hydroxytryptamine (5-HT) receptor subtypes in 5-HT-induced vasoconstriction of the distended human saphenous vein as a coronary artery bypass graft.
Nakamura E; Tanaka N; Kuwabara M; Yamashita A; Matsuo Y; Kanai T; Onitsuka T; Asada Y; Hisa H; Yamamoto R
Biol Pharm Bull; 2011; 34(1):82-6. PubMed ID: 21212522
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the serotonin 5-HT
Baranowska-Kuczko M; Kozłowska H; Schlicker E; Göthert M; MacLean MR; Kozłowski M; Kloza M; Sadowska O; Malinowska B
Pharmacol Rep; 2020 Jun; 72(3):756-762. PubMed ID: 32333296
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of contractile dysfunction induced by serotonin in coronary artery in spontaneously hypertensive rats.
Wang H; Gao XY; Rao F; Yang H; Wang ZY; Liu L; Kuang SJ; Wu Q; Deng CY; Xu JS
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2165-2176. PubMed ID: 31980857
[TBL] [Abstract][Full Text] [Related]
13. Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery.
Rashid M; Nakazawa M; Nagatomo T
Jpn J Pharmacol; 2002 Aug; 89(4):405-12. PubMed ID: 12233819
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies on responsiveness of 5-hydroxytryptamine in overcoming perioperative spasm of coronary artery bypass graft].
Tanaka N
Yakugaku Zasshi; 2009 Sep; 129(9):1049-53. PubMed ID: 19721380
[TBL] [Abstract][Full Text] [Related]
15. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery.
Nishihira K; Yamashita A; Tanaka N; Kawamoto R; Imamura T; Yamamoto R; Eto T; Asada Y
J Thromb Haemost; 2006 Jan; 4(1):247-55. PubMed ID: 16409475
[TBL] [Abstract][Full Text] [Related]
17. Modulation of vasoactivity and platelet aggregation by selective 5-HT receptor antagonism in humans.
Moerland M; Kemme M; Dijkmans A; Bergougnan L; Burggraaf J
J Cardiovasc Pharmacol; 2011 Dec; 58(6):575-80. PubMed ID: 21822145
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
19. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
20. Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle.
Datté JY; Offoumou MA
J Pharm Pharm Sci; 2004 Jan; 7(1):1-7. PubMed ID: 15144728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
